药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Dioxaphetyl butyrate
Tetradecyl hydrogen sulfate (ester)
Ertugliflozin may increase the excretion rate of Tetradecyl hydrogen sulfate (ester) which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
DL-Methylephedrine
Ertugliflozin may increase the excretion rate of DL-Methylephedrine which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Bicisate
Ertugliflozin may increase the excretion rate of Bicisate which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Pyrantel
Ertugliflozin may increase the excretion rate of Pyrantel which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Oxyquinoline
Ertugliflozin may increase the excretion rate of Oxyquinoline which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Chromium
Ertugliflozin may increase the excretion rate of Chromium which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Selenium
Ertugliflozin may increase the excretion rate of Selenium which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Eucalyptus oil
Ertugliflozin may increase the excretion rate of Eucalyptus oil which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
N-acetyltyrosine
Ertugliflozin may increase the excretion rate of N-acetyltyrosine which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Ixazomib
Ertugliflozin may increase the excretion rate of Ixazomib which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Octinoxate
Ertugliflozin may increase the excretion rate of Octinoxate which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Acrivastine
Ertugliflozin may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Potassium perchlorate
Ertugliflozin may increase the excretion rate of Potassium perchlorate which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Magnesium chloride
Ertugliflozin may increase the excretion rate of Magnesium chloride which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Sodium acetate
Ertugliflozin may increase the excretion rate of Sodium acetate which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Phosphoric acid
Ertugliflozin may increase the excretion rate of Phosphoric acid which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Dexpanthenol
Ertugliflozin may increase the excretion rate of Dexpanthenol which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Mersalyl
Ertugliflozin may increase the excretion rate of Mersalyl which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Antihemophilic Factor (Recombinant), PEGylated
Ertugliflozin may increase the excretion rate of Antihemophilic Factor (Recombinant), PEGylated which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Sodium fluoride
Ertugliflozin may increase the excretion rate of Sodium fluoride which could result in a lower serum level and potentially a reduction in efficacy.